Using viruses as nanomedicines
The field of nanomedicine involves the design and fabrication of novel nanocarriers for the intracellular delivery of therapeutic cargo or for use in molecular diagnostics. Although traditionally recognized for their ability to invade and infect host cells, viruses and bacteriophages have been engin...
Gespeichert in:
| Veröffentlicht in: | British journal of pharmacology 2014-09, Vol.171 (17), p.4001-4009 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 4009 |
|---|---|
| container_issue | 17 |
| container_start_page | 4001 |
| container_title | British journal of pharmacology |
| container_volume | 171 |
| creator | Kan‐Davelaar, H E Hest, J C M Cornelissen, J J L M Koay, M S T |
| description | The field of nanomedicine involves the design and fabrication of novel nanocarriers for the intracellular delivery of therapeutic cargo or for use in molecular diagnostics. Although traditionally recognized for their ability to invade and infect host cells, viruses and bacteriophages have been engineered over the past decade as highly promising molecular platforms for the targeted delivery and treatment of many human diseases. Inherently biodegradable, the outer capsids of viruses are composed entirely of protein building blocks, which can be genetically or chemically engineered with molecular imaging reagents, targeting ligands and therapeutic molecules. While there are several examples of viruses as in vitro molecular cargo carriers, their potential for applications in nanomedicine has only recently emerged. Here we highlight recent developments towards the design and engineering of viruses for the treatment of cancer, bacterial infections and immune system‐related diseases.
Linked Articles
This article is part of a themed section on Nanomedicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2014.171.issue‐17 |
| doi_str_mv | 10.1111/bph.12662 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4243974</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1553109199</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5422-9a2f318e993808ad78d484c4ca05daf5f02a5b20150ba54ea2ee95646b726e783</originalsourceid><addsrcrecordid>eNqNkU1LAzEQhoMotlYP_oFS8KKHtUk2nxdBi1qhoAd7Dtlttk3ZZmvSrfTfm7q1qCA4lxzm4ZmZvACcI3iNYvWz5ewaYcbwAWgjwllCU4EOQRtCyBOEhGiBkxDmEMYmp8eghQnliAjZBt1xsG7aW1tfBxN6OvScdtXCTGxunQmn4KjQZTBnu7cDxg_3r4NhMnp-fBrcjpKcEowTqXGRImGkTAUUesLFhAiSk1xDOtEFLSDWNMMQUZhpSozGxkjKCMs4ZoaLtANuGu-yzuLw3LiV16VaervQfqMqbdXPjrMzNa3WimCSSk6i4HIn8NVbbcJKLWzITVlqZ6o6KEQZEyROY_9AaYqgRPGYDrj4hc6r2rv4E1sKUyIp3wqvGir3VQjeFPu9EVTbgFQMSH0GFNnu90P35FciEeg3wLstzeZvk7p7GTbKDxvzl-0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1552549576</pqid></control><display><type>article</type><title>Using viruses as nanomedicines</title><source>MEDLINE</source><source>Wiley Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Kan‐Davelaar, H E ; Hest, J C M ; Cornelissen, J J L M ; Koay, M S T</creator><creatorcontrib>Kan‐Davelaar, H E ; Hest, J C M ; Cornelissen, J J L M ; Koay, M S T</creatorcontrib><description>The field of nanomedicine involves the design and fabrication of novel nanocarriers for the intracellular delivery of therapeutic cargo or for use in molecular diagnostics. Although traditionally recognized for their ability to invade and infect host cells, viruses and bacteriophages have been engineered over the past decade as highly promising molecular platforms for the targeted delivery and treatment of many human diseases. Inherently biodegradable, the outer capsids of viruses are composed entirely of protein building blocks, which can be genetically or chemically engineered with molecular imaging reagents, targeting ligands and therapeutic molecules. While there are several examples of viruses as in vitro molecular cargo carriers, their potential for applications in nanomedicine has only recently emerged. Here we highlight recent developments towards the design and engineering of viruses for the treatment of cancer, bacterial infections and immune system‐related diseases.
Linked Articles
This article is part of a themed section on Nanomedicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2014.171.issue‐17</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/bph.12662</identifier><identifier>PMID: 24571489</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Capsid - chemistry ; Capsid - metabolism ; Drug Delivery Systems - methods ; Genetic Engineering ; Humans ; Ligands ; Medical research ; Molecular Imaging - methods ; Nanomedicine - methods ; Themed Section: Nanomedicine ; Viruses - genetics ; Viruses - immunology ; Viruses - metabolism</subject><ispartof>British journal of pharmacology, 2014-09, Vol.171 (17), p.4001-4009</ispartof><rights>2014 The British Pharmacological Society</rights><rights>2014 The British Pharmacological Society.</rights><rights>Copyright © 2014 The British Pharmacological Society</rights><rights>Copyright © 2014 The British Pharmacological Society 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5422-9a2f318e993808ad78d484c4ca05daf5f02a5b20150ba54ea2ee95646b726e783</citedby><cites>FETCH-LOGICAL-c5422-9a2f318e993808ad78d484c4ca05daf5f02a5b20150ba54ea2ee95646b726e783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243974/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243974/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1417,1433,27924,27925,45574,45575,46409,46833,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24571489$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kan‐Davelaar, H E</creatorcontrib><creatorcontrib>Hest, J C M</creatorcontrib><creatorcontrib>Cornelissen, J J L M</creatorcontrib><creatorcontrib>Koay, M S T</creatorcontrib><title>Using viruses as nanomedicines</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>The field of nanomedicine involves the design and fabrication of novel nanocarriers for the intracellular delivery of therapeutic cargo or for use in molecular diagnostics. Although traditionally recognized for their ability to invade and infect host cells, viruses and bacteriophages have been engineered over the past decade as highly promising molecular platforms for the targeted delivery and treatment of many human diseases. Inherently biodegradable, the outer capsids of viruses are composed entirely of protein building blocks, which can be genetically or chemically engineered with molecular imaging reagents, targeting ligands and therapeutic molecules. While there are several examples of viruses as in vitro molecular cargo carriers, their potential for applications in nanomedicine has only recently emerged. Here we highlight recent developments towards the design and engineering of viruses for the treatment of cancer, bacterial infections and immune system‐related diseases.
Linked Articles
This article is part of a themed section on Nanomedicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2014.171.issue‐17</description><subject>Capsid - chemistry</subject><subject>Capsid - metabolism</subject><subject>Drug Delivery Systems - methods</subject><subject>Genetic Engineering</subject><subject>Humans</subject><subject>Ligands</subject><subject>Medical research</subject><subject>Molecular Imaging - methods</subject><subject>Nanomedicine - methods</subject><subject>Themed Section: Nanomedicine</subject><subject>Viruses - genetics</subject><subject>Viruses - immunology</subject><subject>Viruses - metabolism</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1LAzEQhoMotlYP_oFS8KKHtUk2nxdBi1qhoAd7Dtlttk3ZZmvSrfTfm7q1qCA4lxzm4ZmZvACcI3iNYvWz5ewaYcbwAWgjwllCU4EOQRtCyBOEhGiBkxDmEMYmp8eghQnliAjZBt1xsG7aW1tfBxN6OvScdtXCTGxunQmn4KjQZTBnu7cDxg_3r4NhMnp-fBrcjpKcEowTqXGRImGkTAUUesLFhAiSk1xDOtEFLSDWNMMQUZhpSozGxkjKCMs4ZoaLtANuGu-yzuLw3LiV16VaervQfqMqbdXPjrMzNa3WimCSSk6i4HIn8NVbbcJKLWzITVlqZ6o6KEQZEyROY_9AaYqgRPGYDrj4hc6r2rv4E1sKUyIp3wqvGir3VQjeFPu9EVTbgFQMSH0GFNnu90P35FciEeg3wLstzeZvk7p7GTbKDxvzl-0</recordid><startdate>201409</startdate><enddate>201409</enddate><creator>Kan‐Davelaar, H E</creator><creator>Hest, J C M</creator><creator>Cornelissen, J J L M</creator><creator>Koay, M S T</creator><general>Blackwell Publishing Ltd</general><general>BlackWell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>201409</creationdate><title>Using viruses as nanomedicines</title><author>Kan‐Davelaar, H E ; Hest, J C M ; Cornelissen, J J L M ; Koay, M S T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5422-9a2f318e993808ad78d484c4ca05daf5f02a5b20150ba54ea2ee95646b726e783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Capsid - chemistry</topic><topic>Capsid - metabolism</topic><topic>Drug Delivery Systems - methods</topic><topic>Genetic Engineering</topic><topic>Humans</topic><topic>Ligands</topic><topic>Medical research</topic><topic>Molecular Imaging - methods</topic><topic>Nanomedicine - methods</topic><topic>Themed Section: Nanomedicine</topic><topic>Viruses - genetics</topic><topic>Viruses - immunology</topic><topic>Viruses - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kan‐Davelaar, H E</creatorcontrib><creatorcontrib>Hest, J C M</creatorcontrib><creatorcontrib>Cornelissen, J J L M</creatorcontrib><creatorcontrib>Koay, M S T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kan‐Davelaar, H E</au><au>Hest, J C M</au><au>Cornelissen, J J L M</au><au>Koay, M S T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Using viruses as nanomedicines</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2014-09</date><risdate>2014</risdate><volume>171</volume><issue>17</issue><spage>4001</spage><epage>4009</epage><pages>4001-4009</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>The field of nanomedicine involves the design and fabrication of novel nanocarriers for the intracellular delivery of therapeutic cargo or for use in molecular diagnostics. Although traditionally recognized for their ability to invade and infect host cells, viruses and bacteriophages have been engineered over the past decade as highly promising molecular platforms for the targeted delivery and treatment of many human diseases. Inherently biodegradable, the outer capsids of viruses are composed entirely of protein building blocks, which can be genetically or chemically engineered with molecular imaging reagents, targeting ligands and therapeutic molecules. While there are several examples of viruses as in vitro molecular cargo carriers, their potential for applications in nanomedicine has only recently emerged. Here we highlight recent developments towards the design and engineering of viruses for the treatment of cancer, bacterial infections and immune system‐related diseases.
Linked Articles
This article is part of a themed section on Nanomedicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2014.171.issue‐17</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>24571489</pmid><doi>10.1111/bph.12662</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1188 |
| ispartof | British journal of pharmacology, 2014-09, Vol.171 (17), p.4001-4009 |
| issn | 0007-1188 1476-5381 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4243974 |
| source | MEDLINE; Wiley Journals; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); PubMed Central; Alma/SFX Local Collection |
| subjects | Capsid - chemistry Capsid - metabolism Drug Delivery Systems - methods Genetic Engineering Humans Ligands Medical research Molecular Imaging - methods Nanomedicine - methods Themed Section: Nanomedicine Viruses - genetics Viruses - immunology Viruses - metabolism |
| title | Using viruses as nanomedicines |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T01%3A30%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Using%20viruses%20as%20nanomedicines&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Kan%E2%80%90Davelaar,%20H%20E&rft.date=2014-09&rft.volume=171&rft.issue=17&rft.spage=4001&rft.epage=4009&rft.pages=4001-4009&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1111/bph.12662&rft_dat=%3Cproquest_pubme%3E1553109199%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1552549576&rft_id=info:pmid/24571489&rfr_iscdi=true |